# Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation

> **NCT06448624** · PHASE4 · COMPLETED · sponsor: **Universitas Diponegoro** · enrollment: 60 (actual)

## Conditions studied

- Heart Block
- CIED Related Infection
- CIED-related Infections
- Antibiotic Prophylaxis
- Biomarkers

## Interventions

- **DRUG:** Ampicillin sulbactam 3 days
- **DRUG:** Placebo 3 days

## Key facts

- **NCT ID:** NCT06448624
- **Lead sponsor:** Universitas Diponegoro
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06448624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06448624, "Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06448624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*